AdvisorShares Investments’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

AdvisorShares Investments’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-273,401	Closed	-$1.45M	–	235
2021 Q2	$1.45M	Sell	273,401 -1,264,138	-82%	-$6.08M	0.2%	65
2021 Q1	$7.15M	Buy	1,537,539 +927,494	+152%	+$4.2M	0.89%	18
2020 Q4	$2.01M	Buy	610,045 +257,036	+73%	+$976K	0.47%	22
2020 Q3	$1.17K	Sell	353,009 -27,676	-7%	-$102K	0.06%	58
2020 Q2	$1.28M	Buy	380,685 +27,717	+8%	+$131K	0.55%	24
2020 Q1	$1.35M	Buy	352,968 +83,253	+31%	+$387K	1.17%	13
2019 Q4	$1.63M	Buy	+269,715	New	+$1.84M	1.01%	12

Other funds holding ZYNE

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

AdvisorShares Investments's ZYNE Position: Q3 2021 in Review

AdvisorShares Investments sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q3 2021, closing a stake of 273,401 shares — an estimated $1.45M sold.

AdvisorShares Investments first reported a position in ZYNE in Q4 2019 and held it in 7 quarters. The position peaked at $7.15M in Q1 2021. 58 funds tracked by Wall St. Rank hold ZYNE as of Q3 2021.

AdvisorShares Investments reported no remaining Zynerba Pharmaceuticals, Inc position as of Q3 2021 after selling out during the quarter.
AdvisorShares Investments sold 273,401 Zynerba Pharmaceuticals, Inc shares in Q3 2021, an estimated $1.45M.
AdvisorShares Investments first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2019 and held it in 7 quarters.
AdvisorShares Investments's Zynerba Pharmaceuticals, Inc position peaked at $7.15M in Q1 2021.
58 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q3 2021.

Based on AdvisorShares Investments's 13F filing for Q3 2021, filed 4 Nov 2021.